RxDoctor Payments Data

Monique Lariviere

Nurse Practitioner · Hyannis, MANPI 1407447378

Payments from drug & device makers

$5,519in general payments, 2019–2025

Across 275 payments — averaging $20.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$806
  • GSK$719
  • Boehringer Ingelheim$588
  • Grifols USA, LLC$472
  • Regeneron Healthcare Solutions, Inc.$443
  • Mylan Specialty L.p.$331
  • plus $2K from 21 others

What the payments were for

  • Food & beverage$5,47299%
  • Education$471%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,519 in reported general payments places this provider in the 95th percentile of 3,855 nurse practitioner providers in Massachusetts.

See all nurse practitioner providers in Massachusetts

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter26$22,138
Breztri AerosphereBudesonide/Glycopyr/Formoterol18$16,117
Stiolto RespimatTiotropium Br/Olodaterol Hcl14$8,219
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr11$6,202
Albuterol Sulfate HfaAlbuterol Sulfate14$408
Montelukast Sodium31$390
Famotidine19$213
Tramadol Hcl18$41

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Anoro Ellipta$719$28,34037 claims
AstraZenecaBreztri Aerosphere$806$16,11718 claims
Boehringer IngelheimStiolto Respimat$588$8,21914 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,855 nurse practitioner providers in Massachusetts.

Other nurse practitioner in Hyannis

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →